Equities
Health CarePharmaceuticals & Biotechnology
  • Price (USD)93.01
  • Today's Change0.75 / 0.81%
  • Shares traded364.00k
  • 1 Year change6.32%
  • Beta1.5358
Data delayed at least 15 minutes, as of Sep 24 2018 14:56 BST.
More ▼

Key statistics

As of last trade, AbbVie Inc (ABBV:NYQ) traded at 93.01, 11.80% above the 52 week low of 83.19 set on Sep 27, 2017.
52-week range
Today
83.19Sep 27 2017125.86Jan 26 2018
Markit short selling activity
Low
Med
High
Open92.30
High93.10
Low91.95
Bid92.98
Offer93.03
Previous close92.26
Average volume5.60m
Shares outstanding1.51bn
Free float1.51bn
P/E (TTM)21.53
Market cap139.71bn USD
EPS (TTM)4.29
USD
Annual div (ADY)3.84
USD
Annual div yield (ADY)4.16%
Div ex-dateJul 12 2018
Div pay-dateAug 15 2018
Next div ex-dateOct 12 2018
Next div pay-dateNov 15 2018
Data delayed at least 15 minutes, as of Sep 24 2018 14:56 BST.
More ▼

Investors Chronicle View

The last IC recommendation on AbbVie Inc shares was Hold at 4,801.00 on 16 Jul 2014Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.